Medifast (MED) Misses Q4 EPS by 120c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $11.77 -1.59%
Revenue Growth %: -24.3%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -24.3%
Financial Fact:
Interest income/ (expense), net: 60K
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of ($1.65), $1.20 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $75.1 million versus the consensus estimate of $73.8 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- U.S. and Denmark close in on a Greenland deal - Reuters
- SmartKem (SMTK) files for 15.13M share offering by selling stockholders
- Nscale files for IPO, seeks NYSE listing under ticker NSCL
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
